To add to this, per today's disclosure: 6/25/20
Post# of 30027
(Total Views: 504)
Posted On: 07/09/2019 11:01:28 PM
.jpg)
To add to this, per today's disclosure:
6/25/2019 New 3,333,334 Common $0.009 Debt Conversion unrestricted, upped the float to 128million
Shares outstanding 7/9/2019: 261,384,788
There is ongoing debt conversion.
https://backend.otcmarkets.com/otcapi/company...70/content
There is also a new subsidiary: AMBS Operations LLC: 45 Wall Street, Suite 920, New York, NY 10005
https://www.nvsilverflume.gov/businessSearch
And finally, contrary to the previous confused filing, the Series F is not gone, and yes the Series B is still 100% owned by G.
We'll learn more shortly.
6/25/2019 New 3,333,334 Common $0.009 Debt Conversion unrestricted, upped the float to 128million
Shares outstanding 7/9/2019: 261,384,788
There is ongoing debt conversion.
https://backend.otcmarkets.com/otcapi/company...70/content
There is also a new subsidiary: AMBS Operations LLC: 45 Wall Street, Suite 920, New York, NY 10005
https://www.nvsilverflume.gov/businessSearch
And finally, contrary to the previous confused filing, the Series F is not gone, and yes the Series B is still 100% owned by G.
We'll learn more shortly.
(3)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼